Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,711
Total Claims
$1.3M
Drug Cost
602
Beneficiaries
$2,197
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+87%
Cost per patient vs peers
$2,197 vs $1,174 avg
+78%
Brand preference vs peers
15.7% vs 8.9% avg
Brand vs Generic
Brand: 1,673 claims · $1.1M
Generic: 8,952 claims · $172K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 153 | $124K |
| Semaglutide | 85 | $92K |
| Tirzepatide | 71 | $89K |
| Fluticasone/Umeclidin/Vilanter | 82 | $74K |
| Empagliflozin | 72 | $71K |
| Dulaglutide | 41 | $55K |
| Apixaban | 50 | $45K |
| Cariprazine Hcl | 23 | $34K |
| Denosumab | 20 | $32K |
| Semaglutide | 20 | $32K |
| Budesonide/Formoterol Fumarate | 41 | $29K |
| Mirabegron | 43 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $26K |
| Sitagliptin Phosphate | 26 | $26K |
| Icosapent Ethyl | 51 | $24K |
Prescribing Profile
Patient Profile
72
Avg Age
57%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data